VR Logo

Natco Pharma Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1981

Chairman: V C Nannapaneni

Managing Director: V C Nannapaneni

Group: Natco

Listing: NSE: NATCOPHARM, BSE: 524816

Headquarters: Hyderabad, Telangana

Website: www.natcopharma.co.in

Key Facts

Market cap: R 12,365.15 Cr

Revenue (TTM): R 1,915.00 Cr

Earnings (TTM): R 458.10 Cr

Cash: R 428.20 Cr

Total Debt: R 386.30 Cr

Promoters' ownership: 48.93%

Liquidity: High

52 Week range: R 402.55 - 738.10

Face value: R2.00

Shares outstanding: 18,20,67,975

10 Years Aggregate:

  • CFO: 2,067.60 Cr
  • EBITDA: 3,513.15 Cr
  • Net Profit: 2,430.88 Cr

Stock Performance

Time Period Natco Pharma S&P BSE Healthcare* S&P BSE Mid Cap*
YTD14.4223.40-10.50
1 month12.691.465.83
3 months11.7113.8617.78
1 Year28.4729.91-7.06
3 Years-11.784.43-3.78
5 Years8.50-0.574.26
10 Years32.6511.156.23
As on 13-Jul-2020 *As on 10-Jul-2020
Year Natco Pharma S&P BSE Mid Cap S&P BSE Healthcare
2019-14.53-3.05-3.55
2018-29.15-13.31-5.89
201765.9148.130.49
20160.567.97-12.88
201590.607.4315.06
201488.8454.6947.43
201374.59-5.7322.55